Assessing the Effects of Non-steroidal Anti-inflammatory Drugs on Antihypertensive Drug Therapy Using Post-Marketing Surveillance Database
暂无分享,去创建一个
Toshiharu Fujita | Chieko Ishiguro | Takashi Omori | Takeshi Mayama | T. Omori | Tosiya Sato | Yosuke Fujii | Tosiya Sato | Chieko Ishiguro | Yosuke Fujii | T. Fujita | T. Mayama
[1] Subcommittee Guidelines. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). , 2006, Hypertension research : official journal of the Japanese Society of Hypertension.
[2] H. Black,et al. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. , 2000, Hypertension.
[3] J. Schlesselman,et al. Sample size requirements in cohort and case-control studies of disease. , 1974, American journal of epidemiology.
[4] M Marmot,et al. INTERSALT Study Findings Public Health and Medical Care Implications , 1989, Hypertension.
[5] B. Kuehn. FDA panel: keep COX-2 drugs on market: black box for COX-2 labels, caution urged for all NSAIDs. , 2005, JAMA.
[6] Lippincott Williams Wilkins,et al. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.
[7] Arterial hypertension. Report of a WHO expert committee. , 1978, World Health Organization technical report series.
[8] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[9] D. Young,et al. Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. , 1995, American journal of hypertension.
[10] M. Leider. Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .
[11] Trefor Owen Morgan,et al. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. , 2000, American journal of hypertension.
[12] W. White. Hypertension associated with therapies to treat arthritis and pain. , 2004, Hypertension.
[13] J. Gerber,et al. Propranolol Increases Prostacyclin Synthesis in Patients with Essential Hypertension , 1988, Hypertension.
[14] J. Robins,et al. Estimating exposure effects by modelling the expectation of exposure conditional on confounders. , 1992, Biometrics.
[15] Roger L. Black,et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .
[16] R. Day,et al. Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis , 1994, Annals of Internal Medicine.
[17] H. Friza. Report of a WHO Expert Committee. (WHO Technical Report Series No. 807), VI. World Health Organization, Geneva (1991), 65 pages, Soft cover SFr. 11 , 1993 .
[18] T. Saruta. [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[19] A. Hida,et al. Basic Characteristics of Chronic Hypotension Cases: A Longitudinal Follow-Up Study from 1958 through 1999 , 2006, Hypertension Research.
[20] J. Ménard,et al. Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. , 1993, BMJ.
[21] G. Ruoff. The impact of nonsteroidal anti-inflammatory drugs on hypertension: alternative analgesics for patients at risk. , 1998, Clinical therapeutics.
[22] F. Arellano. The withdrawal of rofecoxib , 2005, Pharmacoepidemiology and drug safety.